Hot Topics Banner

Bone Marrow Genetic Studies for Malignant Lymphoma Staging

Optimizing Laboratory Testing for Hematologic Disorders Series

Click CC to turn on closed captioning.

January 2013

Dr. Kurtin presents the third in our series “Optimizing Laboratory Testing for Hematologic Disorders.” The series addresses guidelines for appropriate laboratory test utilization in hematologic disorders. This presentation will discuss the appropriate utilization of genetic testing when evaluating the bone marrow for involvement by malignant lymphomas.


  • Paul J. Kurtin, MD
    • Consultant in the Division of Hematopathology, Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota

Related Tests

Hematologic Disorders Series

Print Options

Forward to a Colleague

Share this presentation with:

  • Hematologists
  • Hematopathologists
  • Hematology Oncologists
  • Laboratory Managers

If you have questions, email .